期刊文献+

心力衰竭与血浆B型利钠肽相关分析 被引量:1

原文传递
导出
摘要 目的探讨心力衰竭患者血浆B型利钠肽(BNP)浓度变化及其临床评价。方法采用化学发光法测定200例(100例住院心力衰竭患者及100例健康对照者)血浆BNP浓度。结果心力衰竭患者组血浆BNP水平显著高于健康对照组(P<0.001),且患者血浆BNP水平与心力衰竭严重程度呈正相关(r=0.95)。结论心力衰竭患者血浆BNP浓度显著升高,且与心力衰竭严重程度成正比,具有重要的临床意义。
作者 邓俊国
出处 《中国误诊学杂志》 CAS 2011年第15期3572-3573,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献5

二级参考文献31

  • 1周琰,陶青,潘柏申.B型利钠肽在心脏疾病中的应用[J].诊断学理论与实践,2004,3(5):376-381. 被引量:18
  • 2Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure [ J ]. Am J Cardiol,2004,93 (9) :1124- 1129.
  • 3Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy [ J ]. Circulation, 2003,108 (7) : 839 -843.
  • 4Sola S, Mir MQ, Lerakis S, et al. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure [ J]. J Am Coll Cardiol,2006,47 (2) :332-337.
  • 5Khush KK, Waters DD, Bittner V,et al. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study [ J]. Circulation,2007,115:576-583.
  • 6Scirica BM,Morrow DA,Cannon CP,et al. PROVE IT-TIMI 22 Investigators. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study [ J ]. J Am Coll Cardiol, 2006,47 : 2326 -2631.
  • 7Heart Protection Study Collaborative Group, Emberson JR, Ng LL, et al. N-terminal pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study [ J ]. J Am Coll Cardiol,2007,49:311-319.
  • 8Foody AM, Shah R, Galusha D, et al. Statins and mortality among elderly patients hospitalized with heart failure [ J ]. Circulation ,2006,113 : 1086-1092.
  • 9Tavazzi L, Tognoni G, Franzosi MG, et al. Rationale and design of the GISSI heart failure trial:a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure [ J ]. Eur J Heart Fail,2004,6 (5) :635-641.
  • 10Kjekshus J, Dunselman P, Blideskog M, et al. A statin in the treatment of heart failure ? Controlled rosuvastatin multinational study in heart failure (CORONA) : study design and baseline characteristics [ J ]. Eur J Heart Fail, 2005,7:1059- 1069.

共引文献298

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部